Malaria, a mosquito-borne infectious disease, occurs commonly in tropical and sub-tropical regions. The malaria diagnostics market was worth about USD 145 million in 2015. It would grow to around USD 179 million by 2022. This may be attributed to potentially fatal illnesses globally. Around 3.3 billion people across the world face high infliction risks.
Demand for malaria diagnostics is driven by awareness regarding diagnostic tests. Also, people prefer superior-quality, yet affordable diagnostic methods. This brings about technological advancements. Modern & innovative technologies are expected to deliver higher efficiencies, thereby propelling market demand.
Full research report on Malaria Market Analysis: http://www.grandviewresearch.com/industry-analysis/malaria-diagnostics-market
A key challenge for the malaria diagnostics market is malarial elimination in several countries. Oman, Iraq, Argentina, Armenia, etc. reported nil new indigenous cases of the disease in 2014. Moreover, El Salvador and Algeria reported less than 10 cases the same year. The WHO confirms that global fatalities from malaria have reduced by 60% since 2, 000.
The market may be segmented on the basis of diagnostic technologies and geographies. The diagnostic technologies are microscopy, rapid diagnostics tests (RDTs), and others. RDTs accounted for the largest share (over 62%) in 2015. They will be the fastest-growing (CAGR of 4%) technology in the next seven years.
Their advantages include fast results and high sensitivity. Moreover, RDTs do not require highly-skilled manpower. Therefore, they can be employed in remote areas like Africa, which lack good healthcare infrastructure and microscopy services.
India, with over 122 slide examinations, was the leading country for microscopy diagnostic technology in 2013. Globally, more than 190 million people were tested using this technology that year. Regional segmentation of the malaria diagnostics market consists of Europe, Africa, Eastern Mediterranean, Americas, South-East Asia, and Western Pacific.
Request for sample of this research report: http://www.grandviewresearch.com/industry-analysis/malaria-diagnostics-market/request
Africa’s share in the total volumes was almost 60% in 2015. Factors that contributed to its dominance were poverty, climatic conditions, under-developed healthcare facilities, and widespread proliferation of the plasmodium ‘falciparum.’ South-East Asia was predicted to occupy second place in 2015. India should dominate this region in the forthcoming years. Its expected CAGR is about 3.8% from 2015 to 2022.
Prominent players in the worldwide malaria diagnostics market comprise Access Bio Inc., Beckman Coulter Inc., Premier Medical Corporation, and Alere Inc. Their competitive strategies include new product developments, technological advancements, and collaborations.
View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/clinical-diagnostics
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Web: www.grandviewresearch.com
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: sales@grandviewresearch.com
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: http://www.grandviewresearch.com/industry-analysis/malaria-diagnostics-market